AI Empowers Patients to Navigate Cancer Care
An AACR Patient Advocate Forum assembled a panel of experts to discuss how AI tools can help advance cancer...
An AACR Patient Advocate Forum assembled a panel of experts to discuss how AI tools can help advance cancer...
Patient advocates from the AACR Scientist↔Survivor Program shared their research on cancer during the AACR Annual Meeting 2026.
Injecting immunotherapy directly into precancerous oral lesions may be an effective way to prevent progression to cancer without surgery.
The spring 2026 issue of Cancer Today included articles about using AI chatbots, cancer survivor—and “Survivor” winner—Ethan Zohn, and...
Epidemiologist Elizabeth A. Platz explains what goes into calculating cancer risk estimates, such as rate ratio, hazard ratio, and...
Colorectal cancer cases are becoming more common in younger adults, but there are now more options for screening beyond...
Researchers and a patient advocate weighed in on current and emerging treatment options for each stage of triple-negative breast...
Cancer Today's winter 2025-2026 issue covers delaying stem cell transplants in multiple myeloma, new treatments for brain metastases, and...
What are fusion proteins? Learn more about how improperly combined genes and their protein products can lead to cancer.
An AACR Special Conference on early-onset cancers explored possible explanations for the alarming increase in cancer among younger adults.